- Home
- CCEP vs CAH Comparison
CCEP vs CAH Comparison
Compare CCEP & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEP
- CAH
- Stock Information
- Founded
- CCEP 1986
- CAH 1979
- Country
- CCEP United Kingdom
- CAH United States
- Employees
- CCEP N/A
- CAH N/A
- Industry
- CCEP Beverages (Production/Distribution)
- CAH Other Pharmaceuticals
- Sector
- CCEP Consumer Staples
- CAH Health Care
- Exchange
- CCEP Nasdaq
- CAH Nasdaq
- Market Cap
- CCEP 35.8B
- CAH 30.3B
- IPO Year
- CCEP 1987
- CAH N/A
- Fundamental
- Price
- CCEP $75.17
- CAH $118.30
- Analyst Decision
- CCEP Strong Buy
- CAH Buy
- Analyst Count
- CCEP 9
- CAH 12
- Target Price
- CCEP $84.50
- CAH $125.92
- AVG Volume (30 Days)
- CCEP 1.7M
- CAH 2.3M
- Earning Date
- CCEP 08-07-2024
- CAH 01-30-2025
- Dividend Yield
- CCEP 2.83%
- CAH 1.71%
- EPS Growth
- CCEP N/A
- CAH 539.70
- EPS
- CCEP 3.75
- CAH 5.21
- Revenue
- CCEP $20,521,804,348.00
- CAH $224,454,000,000.00
- Revenue This Year
- CCEP $13.73
- CAH N/A
- Revenue Next Year
- CCEP $5.46
- CAH $8.17
- P/E Ratio
- CCEP $20.24
- CAH $22.71
- Revenue Growth
- CCEP 6.31
- CAH 6.87
- 52 Week Low
- CCEP $64.25
- CAH $93.17
- 52 Week High
- CCEP $82.32
- CAH $126.23
- Technical
- Relative Strength Index (RSI)
- CCEP 38.98
- CAH 48.44
- Support Level
- CCEP $77.18
- CAH $115.00
- Resistance Level
- CCEP $79.71
- CAH $126.23
- Average True Range (ATR)
- CCEP 1.53
- CAH 2.61
- MACD
- CCEP -0.40
- CAH -0.72
- Stochastic Oscillator
- CCEP 16.55
- CAH 31.81
About CCEP Coca-Cola Europacific Partners plc
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe (80% of 2023 revenue and EBIT) and Australasia (20%).In 2023, CCEP sold 3.3 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume. Coke's largest bottler, Coca-Cola Femsa sold 4 billion unit cases (12%), and the third-largest, Coca-Cola HBC, serving Eastern Europe and North Africa, sold 2.8 billion unit cases (8%).TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.